These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14902775)

  • 21. FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. II. DEVELOPMENT AND PERSISTENCE OF ANTIBODIES TO PLASMODIUM FALCIPARUM.
    COLLINS WE; JEFFERY GM; SKINNER JC
    Am J Trop Med Hyg; 1964 Mar; 13():256-60. PubMed ID: 14125876
    [No Abstract]   [Full Text] [Related]  

  • 22. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 24. The gametocytocidal action of paludrine upon infections of Plasmodium falciparum.
    SHUTE PG; MARYON M
    Parasitology; 1948 Feb; 38(4):264-70. PubMed ID: 18907589
    [No Abstract]   [Full Text] [Related]  

  • 25. Proguanil daily or chlorproguanil twice weekly are efficacious against falciparum malaria in a holoendemic area of Tanzania.
    Rooth I; Sinani HM; Björkman A
    J Trop Med Hyg; 1991 Feb; 94(1):45-9. PubMed ID: 1995934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired resistance to proguanil in Plasmodium falciparum.
    SEATON DR; ADAMS AR
    Lancet; 1949 Aug; 2(6573):323. PubMed ID: 18137351
    [No Abstract]   [Full Text] [Related]  

  • 27. DRUG-RESISTANT FALCIPARUM MALARIA FROM CAMBODIA AND MALAYA.
    CONTACOS PG; LUNN JS; COATNEY GR
    Trans R Soc Trop Med Hyg; 1963 Nov; 57():417-24. PubMed ID: 14081296
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies in human malaria. XXVIII. Observations on the use of chloroguanide against the Chesson strain of Plasmodium vivax.
    COOPER WC; COATNEY GR; JEFFERY GM; IMBODEN CA
    J Natl Malar Soc; 1950 Dec; 9(4):366-76. PubMed ID: 14804096
    [No Abstract]   [Full Text] [Related]  

  • 29. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro.
    Rieckmann KH; McNamara JV; Frischer H; Stockert TA; Carson PE; Powell RD
    Am J Trop Med Hyg; 1968 Sep; 17(5):661-71. PubMed ID: 4877713
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
    Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
    Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro studies on the sensitivities of Plasmodium falciparum in Thailand to pyrimethamine and proguanil.
    Sucharit F; Tiewcharoen S; Chintana T; Suphadtanaphongs V; Sucharit S
    Ann Trop Med Parasitol; 1985 Aug; 79(4):375-7. PubMed ID: 3907557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 36. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proguanil/sulfamethoxazole malaria chemoprophy-laxis on the Thai-Cambodian border.
    Karwacki JJ; Shanks GD; Suriyamongkol V; Watanasook C
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):77-80. PubMed ID: 1948264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
    Anabwani G; Canfield CJ; Hutchinson DB
    Pediatr Infect Dis J; 1999 May; 18(5):456-61. PubMed ID: 10353520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.